Fatty acid uptake by breast cancer cells (MDA-MB-231): Effects of insulin, leptin, adiponectin, and TNFα

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 2-3, 2009, Pages 93-99

  Kaur, Baljit ^a   Jørgensen, Aud ^a   Duttaroy, Asim K ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Adiponectin; Arachidonic acid; EPA; Fatty acid uptake; Insluin; TNF

Indexed keywords

ADIPONECTIN; ARACHIDONIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; INSULIN; LEPTIN; OLEIC ACID; PHOSPHOLIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL; CANCER RISK; CYTOTOXICITY; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; HUMAN; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL;

ADIPONECTIN; ARACHIDONIC ACID; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHOLESTEROL ESTERS; DIGLYCERIDES; EICOSAPENTAENOIC ACID; FATTY ACIDS; FEMALE; HUMANS; INSULIN; LEPTIN; OLEIC ACID; PHOSPHOLIPIDS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61849142214     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.01.002     Document Type: Article

References (55)

1. Byrne C., Rockett H., and Holmes M.D. Dietary fat, fat subtypes, and breast cancer risk: lack of an association among postmenopausal women with no history of benign breast disease. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 261-265
2. Velie E., Kulldorff M., Schairer C., Block G., Albanes D., and Schatzkin A. Dietary fat, fat subtypes, and breast cancer in postmenopausal women: a prospective cohort study. J. Natl. Cancer Inst. 92 (2000) 833-839
3. Bagga D., Anders K.H., Wang H.J., and Glaspy J.A. Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr. Cancer 42 (2002) 180-185
4. Maillard V., Bougnoux P., Ferrari P., Jourdan M.L., Pinault M., Lavillonniere F., Body G., Le F.O., and Chajes V. N-3 and N-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int. J. Cancer 98 (2002) 78-83
5. Klein V., Chajes V., Germain E., Schulgen G., Pinault M., Malvy D., Lefrancq T., Fignon A., Le F.O., Lhuillery C., and Bougnoux P. Low alpha-linolenic acid content of adipose breast tissue is associated with an increased risk of breast cancer. Eur. J. Cancer 36 (2000) 335-340
6. Schley P.D., Jijon H.B., Robinson L.E., and Field C.J. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 92 (2005) 187-195
7. Mukutmoni-Norris M., Hubbard N.E., and Erickson K.L. Modulation of murine mammary tumor vasculature by dietary n-3 fatty acids in fish oil. Cancer Lett. 150 (2000) 101-109
8. Wu M., Harvey K.A., Ruzmetov N., Welch Z.R., Sech L., Jackson K., Stillwell W., Zaloga G.P., and Siddiqui R.A. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int. J. Cancer 117 (2005) 340-348
9. Sauer L.A., Dauchy R.T., Blask D.E., Krause J.A., Davidson L.K., and Dauchy E.M. Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J. Nutr. 135 (2005) 2124-2129
10. Goodstine S.L., Zheng T., Holford T.R., Ward B.A., Carter D., Owens P.H., and Mayne S.T. Dietary (n-3)/(n-6) fatty acid ratio: possible relationship to premenopausal but not postmenopausal breast cancer risk in US women. J. Nutr. 133 (2003) 1409-1414
11. Simonsen N.R., Fernandez-Crehuet N.J., Martin-Moreno J.M., Strain J.J., Huttunen J.K., Martin B.C., Thamm M., Kardinaal A.F., van't V.P., Kok F.J., and Kohlmeier L. Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study. European community multicenter study on antioxidants, myocardial infarction, and breast cancer. Am. J. Clin. Nutr. 68 (1998) 134-141
12. Terry P., Rohan T.E., Wolk A., Maehle-Schmidt M., and Magnusson C. Fish consumption and breast cancer risk. Nutr. Cancer 44 (2002) 1-6
13. Folsom A.R., and Demissie Z. Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women. Am. J. Epidemiol. 160 (2004) 1005-1010
14. Engeset D., Alsaker E., Lund E., Welch A., Khaw K.T., Clavel-Chapelon F., Thiebaut A., Chajes V., Key T.J., Allen N.E., Amiano P., Dorronsoro M., Tjonneland A., Stripp C., Peeters P.H., van Gils C.H., Chirlaque M.D., Nagel G., Linseisen J., Ocke M.C., Bueno-de-Mesquita H.B., Sacerdote C., Tumino R., Ardanaz E., Sanchez M.J., Panico S., Palli D., Trichopoulou A., Kalapothaki V., Benetou V., Quiros J.R., Agudo A., Overvad K., Bjerregaard L., Wirfalt E., Schulz M., Boeing H., Slimani N., and Riboli E. Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 119 (2006) 175-182
15. Chajes V., and Bougnoux P. Omega-6/omega-3 polyunsaturated fatty acid ratio and cancer. World Rev. Nutr. Diet. 92 (2003) 133-151
16. Chajes V., Lavillonniere F., Maillard V., Giraudeau B., Jourdan M.L., Sebedio J.L., and Bougnoux P. Conjugated linoleic acid content in breast adipose tissue of breast cancer patients and the risk of metastasis. Nutr. Cancer 45 (2003) 17-23
17. Honn K.V., Tang D.G., Gao X., Butovich I.A., Liu B., Timar J., and Hagmann W. 12-lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev. 13 (1994) 365-396
18. Tang D.G., Renaud C., Stojakovic S., Diglio C.A., Porter A., and Honn K.V. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem. Biophys. Res. Commun. 211 (1995) 462-468
19. Duttaroy A.K. Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: effects of essential fatty acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids 51 (1994) 385-399
20. Rose D.P., Komninou D., and Stephenson G.D. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 5 (2004) 153-165
21. Wolf I., Sadetzki S., Catane R., Karasik A., and Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol. 6 (2005) 103-111
22. Stephenson G.D., and Rose D.P. Breast cancer and obesity: an update. Nutr. Cancer 45 (2003) 1-16
23. Del Giudice M.E., Fantus I.G., Ezzat S., Keown-Eyssen G., Page D., and Goodwin P.J. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res. Treat. 47 (1998) 111-120
24. Papa V., and Belfiore A. Insulin receptors in breast cancer: biological and clinical role. J. Endocrinol. Invest 19 (1996) 324-333
25. Miyaoka K., Kuwasako T., Hirano K., Nozaki S., Yamashita S., and Matsuzawa Y. CD36 deficiency associated with insulin resistance. Lancet 357 (2001) 686-687
26. Yanai H., Chiba H., Fujiwara H., Morimoto M., Takahashi Y., Hui S.P., Fuda H., Akita H., Kurosawa T., Kobayashi K., and Matsuno K. Metabolic changes in human CD36 deficiency displayed by glucose loading. Thromb. Haemost. 86 (2001) 995-999
27. Hajri T., Han X.X., Bonen A., and Abumrad N.A. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Invest 109 (2002) 1381-1389
28. Schaffler A., Scholmerich J., and Buechler C. Mechanisms of disease: adipokines and breast cancer-endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 345-354
29. Fraser S.P., Diss J.K., Chioni A.M., Mycielska M.E., Pan H., Yamaci R.F., Pani F., Siwy Z., Krasowska M., Grzywna Z., Brackenbury W.J., Theodorou D., Koyuturk M., Kaya H., Battaloglu E., De Bella M.T., Slade M.J., Tolhurst R., Palmieri C., Jiang J., Latchman D.S., Coombes R.C., and Djamgoz M.B. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin. Cancer Res. 11 (2005) 5381-5389
30. Campbell F.M., Clohessy A.M., Gordon M.J., Page K.R., and Duttaroy A.K. Uptake of long chain fatty acids by human placental choriocarcinoma (BeWo) cells: role of plasma membrane fatty acid binding protein. Journal of Lipid Research 38 (1997) 2558-2568
31. Crabtree J.T., Gordon M.J., Campbell F.M., and Duttaroy A.K. Differential distribution and metabolism of arachidonic acid and docosahexaenoic acid by human placental choriocarcinoma (BeWo) cells. Molecular and Cellular Biochemistry 185 (1998) 191-198
32. Potashnik R., Bloch-Damti A., Bashan N., and Rudich A. IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia 46 (2003) 639-648
33. Schmitz G., and Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 47 (2008) 147-155
34. Horia E., and Watkins B.A. Comparison of stearidonic acid and alpha-linolenic acid on PGE2 production and COX-2 protein levels in MDA-MB-231 breast cancer cell cultures. J. Nutr. Biochem. 16 (2005) 184-192
35. Duttaroy A.K. Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. Cellular and Molecular Life Sciences 57 (2000) 1360-1372
36. Finstad H.S., Dyrendal H., Myhrstad M.C., Heimli H., and Drevon C.A. Uptake and activation of eicosapentaenoic acid are related to accumulation of triacylglycerol in Ramos cells dying from apoptosis. J. Lipid Res. 41 (2000) 554-563
37. Schurer N.Y., Stremmel W., Grundmann J.U., Schliep V., Kleinert H., Bass N.M., and Williams M.L. Evidence for a novel keratinocyte fatty acid uptake mechanism with preference for linoleic acid: comparison of oleic and linoleic acid uptake by cultured human keratinocytes, fibroblasts and a human hepatoma cell line. Biochim. Biophys. Acta 1211 (1994) 51-60
38. Uriel J., Torres J.M., and Anel A. Carrier-protein-mediated enhancement of fatty-acid binding and internalization in human T-lymphocytes. Biochim. Biophys. Acta 1220 (1994) 231-240
39. Stoll B.A. Upper abdominal obesity, insulin resistance and breast cancer risk. Int. J. Obes. Relat Metab Disord. 26 (2002) 747-753
40. Muti P., Quattrin T., Grant B.J.B., Krogh V., Micheli A., Schunemann H.J., Ram M., Freudenheim J.L., Sieri S., Trevisan M., and Berrino F. Fasting glucose is a risk factor For breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 11 (2002) 1361-1368
41. Straus D.S. Growth-stimulatory actions of insulin in vitro and in vivo. Endocr. Rev. 5 (1984) 356-369
42. Lippman M.E., Osborne C.K., Knazek R., and Young N. In vitro model systems for the study of hormone-dependent human breast cancer. N. Engl. J. Med. 296 (1977) 154-159
43. Osborne C.K., Bolan G., Monaco M.E., and Lippman M.E. Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. Proc. Natl. Acad. Sci. USA 73 (1976) 4536-4540
44. Papa V., and Belfiore A. Insulin receptors in breast cancer: biological and clinical role. J. Endocrinol. Invest. 19 (1996) 324-333
45. Costantino A., Milazzo G., Giorgino F., Russo P., Goldfine I.D., Vigneri R., and Belfiore A. Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity. Mol. Endocrinol. 7 (1993) 1667-1676
46. Barb D., Williams C.J., Neuwirth A.K., and Mantzoros C.S. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am. J. Clin. Nutr. 86 (2007) s858-s866
47. Mantzoros C., Petridou E., Dessypris N., Chavelas C., Dalamaga M., Alexe D.M., Papadiamantis Y., Markopoulos C., Spanos E., Chrousos G., and Trichopoulos D. Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab. 89 (2004) 1102-1107
48. Miyoshi Y., Funahashi T., Kihara S., Taguchi T., Tamaki Y., Matsuzawa Y., and Noguchi S. Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res. 9 (2003) 5699-5704
49. Wolf I., Sadetzki S., Kanety H., Kundel Y., Pariente C., Epstein N., Oberman B., Catane R., Kaufman B., and Shimon I. Adiponectin, ghrelin, leptin in cancer cachexia in breast, colon cancer patients. Cancer 106 (2006) 966-973
50. Wang Y., Lam J.B., Lam K.S., Liu J., Lam M.C., Hoo R.L., Wu D., Cooper G.J., and Xu A. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 66 (2006) 11462-11470
51. Dieudonne M.N., Bussiere M., Dos Santos E., Leneveu M.C., Giudicelli Y., and Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 345 (2006) 271-279
52. Wang Y., Lam J.B., Lam K.S., Liu J., Lam M.C., Hoo R.L., Wu D., Cooper G.J., and Xu A. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 66 (2006) 11462-11470
53. Stattin P., Soderberg S., Biessy C., Lenner P., Hallmans G., Kaaks R., and Olsson T. Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res. Treat. 86 (2004) 191-196
54. Wang L., Lim E.J., Toborek M., and Hennig B. The role of fatty acids and caveolin-1 in tumor necrosis factor a-induced endothelial cell activation. Metabolism Clin. Exptl. 57 (2008) 1328-1339
55. Pohl J., Ring A., Ehehalt R., Herrmann T., and Stremmel W. New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. Proc. Nutr. Soc. 63 (2004) 259-262